Neo7Logix provides full scale genetic analytical service for patients suffering with disease and also for healthy individuals. We combine analyses of all kinds of personalized OMICs data to build a comprehensive model of a patient's disease molecular mechanisms and then design personalized therapy.
We develop personalized and unique approaches to the specific individual patient’s health in several ways. We select or reposition FDA-approved drugs by matching mechanisms of disease and mechanism of drug action. We design personalized therapeutic peptides for cancer vaccine and reverse vaccination for autoimmune disorders. Additionally, we create personalized diet and natural supplements recommendations.
Neo7Logix handles each individual patient uniquely and specifically for a custom fit of the peptides to bolster that one individual's specific immune system needs. No two people are treated the same way.
For cancer patients Neo7Logix compares tumor genetics with the patient’s genetics to find somatic mutations driving tumor progression. Then we design a personalized cancer vaccines to activate that patient's immune system against their tumor. It's the specificity of the analysis of the single individual that gives the peptides such a unique approach. Other companies use “off the shelf” peptides whereas Neo7Logix custom makes the needed peptides for the individual out of over 400 billion choices.
In patients with autoimmune disease, Neo7Logix designs peptides for reverse vaccination to deactivate the immune system mistakenly attacking a patient's internal organs. Neo7Logix stands out in the marketplace as the only company offering integrated analysis of the entire patient genetics, tumor transcriptome and urine proteomics to identify precise molecular malignancies (faults) driving the disease or genetic variations predisposing to disease.
Neo7Logix utilizes Elsevier Pathway Studio, which stores the most robust disease hallmark database in molecular biology with knowledge-graph derived from the scientific literature. Neo7Logix’s power is in the application of statistical and artificial intelligence algorithms to analyze the complete patient genetics together with complementary patient OMICs data coupled with the most extensive molecular biology knowledgebase.